ANGUS Chemical taps Havelka as next vice president of R&D
Photo courtesy of ANGUS Chemical

ANGUS Chemical taps Havelka as next vice president of R&D

ANGUS Chemical Company, a leading global manufacturer and marketer of specialty chemicals for Life Sciences and Industrial markets based in Buffalo Grove, Illinois, U.S.A., has appointed Dr. Kathleen Havelka as vice president of Research and Development (R&D). 

She succeeds Dr. David Green who will retire at the end of April. She will report to ANGUS President and CEO David Neuberger.

Havelka is a chemical industry veteran with more than 25 years’ experience in numerous leadership roles in multinational specialty chemical and industrial products organizations. She joins ANGUS from Fuchs Lubricants Company, where she most recently served as senior director of R&D and Quality Control. Prior to Fuchs, she held significant roles in R&D, sales and marketing at Elevance Renewable Sciences, Diversey (Johnson-Diversey) and Lubrizol Corporation.

“Kathleen has an impressive track record of leading innovation, driving the introduction of new technologies, fostering collaboration and finding improved technical solutions to support growth,” said Neuberger. “She brings a deep understanding of the strategic end markets we serve, as well as the diversified needs of our customers around the world. I look forward to the addition of Kathleen’s experience and scientific expertise to the ANGUS Leadership Team.”

Havelka holds a bachelor’s degree in chemistry from Elmhurst College and a doctorate in chemistry from Northern Illinois University. She holds several patents and has been credited with multiple publications and presentations. A recipient of several technical awards, she has been a member of external technical boards.  

“Dave has made significant contributions to ANGUS and our customers over the past 25 years through his deep understanding and passion for ANGUS chemistries and their limitless potential,” added Neuberger. “I am deeply grateful for his dedication and leadership during a very transformative time for the company and wish him a long, happy and healthy retirement.”